RENEO PHARMACEUTICALS, INC.

Insiders Reneo Pharmaceuticals, Inc.

Equities

RPHM

US75974E1038

Real-time Estimate Cboe BZX Other stock markets 14:30:19 15/05/2024 BST			5-day change	1st Jan Change
1.58 ^USD	-2.47%		-6.90%	+1.25%

05-13	Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise	MT
05-13	OnKure, Inc. entered into an agreement to acquire Reneo Pharmaceuticals, Inc.	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Insider Buy: Reneo Pharmaceuticals	10/05/23	MT
Reneo Pharmaceuticals, Inc. Appoints Roshawn Blunt to Its Board of Directors	02/08/22	CI
Dr. Lon Cardon Not Stands for Re-Election as Member of the Board of Reneo Pharmaceuticals, Inc	22/04/22	CI
Reneo Pharmaceuticals Names New COO	07/03/22	MT
Reneo Pharmaceuticals, Inc. Announces Senior Leadership Promotions	07/03/22	CI
Vineet R. Jindal to Resign as Reneo Pharmaceuticals, Inc.'s Chief Financial Officer, Effective March 31, 2022	02/02/22	CI
Reneo Pharmaceuticals Announces Changes to its Board of Directors	24/01/22	CI
Reneo Pharmaceuticals, Inc. Announces Board Changes	27/12/21	CI
Reneo Pharmaceuticals, Inc. Appoints Ashley F. Hall as Chief Development Officer	11/10/21	CI
Reneo Pharmaceuticals, Inc. Announces Retirement of Wendy Johnson as Chief Development Officer, Effective on or Before December 31, 2021	14/05/21	CI
Reneo Pharmaceuticals Appoints Vineet R. Jindal as its Chief Financial Officer	22/03/21	CI
Reneo Pharmaceuticals, Inc. Appoints Eric Dube to Its Board of Directors	15/03/21	CI
Reneo Pharmaceuticals, Inc. Appoints Gregory J. Flesher as President and A Member of the Board of Directors	09/12/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer